xSafety, Tolerability, and Pharmacokinetics of Crenezumab...

  • Main
  • 2020 / 06
  • xSafety, Tolerability, and Pharmacokinetics of Crenezumab...
Journal of Alzheimer's Disease 2020 / 06

xSafety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-To-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks

Guthrie, Heather, Honig, Lawrence S., Lin, Helen, Sink, Kaycee M., Blondeau, Kathleen, Quartino, Angelica, Dolton, Michael, Carrasco-Triguero, Montserrat, Lian, Qinshu, Bittner, Tobias, Clayton, David
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Alzheimer's Disease
DOI:
10.3233/JAD-200134
Date:
June, 2020
File:
PDF, 294 KB
2020
Conversion to is in progress
Conversion to is failed